The conversation around GLP-1 medications has exploded over the past year. These therapies are changing the way we think about obesity and weight management, offering new hope to millions of people who have struggled with traditional methods of weight loss. But as employers, providers, and payers weigh the questions of coverage, step programs, and mandatory...Read More

There’s something happening in the world of employer-sponsored healthcare that should make all of us pause. As GLP-1 medications like Ozempic, Wegovy, and Mounjaro take off as tools for weight management and metabolic health, employers are asking how to offer these drugs responsibly, by pairing them with lifestyle and nutrition programs that drive long-term success....Read More